Gritstone bio Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016
Revenue	16.34	19.95	48.21	4.04	4.37	1.19	0	0
Revenue Growth (YoY)	-18.05%	-58.63%	1094.30%	-7.51%	267.73%	-	-	-
Gross Profit	16.34	19.95	48.21	4.04	4.37	1.19	0	0
Selling, General & Admin	28.78	28.97	25.93	21.41	19.41	11.81	6.07	5.06
Research & Development	127.18	111.4	97.49	88.64	82.9	54.97	35.69	13.92
Other Operating Expenses	0.03	0	0	0	0	0	0	0
Operating Expenses	156	140.37	123.42	110.05	102.31	66.77	41.76	18.98
Operating Income	-139.65	-120.43	-75.21	-106.02	-97.94	-65.58	-41.76	-18.98
Interest Expense / Income	4.04	1.24	0.04	0.01	0	0	0	0
Other Expense / Income	-5.2	-1.98	-0.16	-0.72	-3.51	-0.8	-0.32	-0.23
Pretax Income	-138.49	-119.69	-75.08	-105.31	-94.43	-64.79	-41.45	-18.75
Net Income	-138.49	-119.69	-75.08	-105.31	-94.43	-64.79	-41.45	-18.75
Shares Outstanding (Basic)	116	91	79	38	34	9	2	2
Shares Outstanding (Diluted)	116	91	79	38	34	9	2	2
Shares Change	27.07%	15.25%	108.73%	12.63%	276.21%	346.18%	19.52%	-
EPS (Basic)	-1.20	-1.32	-0.95	-2.79	-2.81	-7.26	-20.70	-11.21
EPS (Diluted)	-1.20	-1.32	-0.95	-2.79	-2.81	-7.26	-20.70	-11.21
Free Cash Flow	-126.22	-121.82	-56.38	-92.62	-101.18	-43.83	-46.46	-22.28
Free Cash Flow Per Share	-1.09	-1.34	-0.71	-2.45	-3.02	-4.91	-23.24	-13.32
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	-	-
Operating Margin	-854.46%	-603.80%	-155.99%	-2626.13%	-2243.76%	-5525.19%	-	-
Profit Margin	-847.34%	-600.09%	-155.73%	-2608.72%	-2163.41%	-5457.96%	-	-
Free Cash Flow Margin	-772.27%	-610.77%	-116.93%	-2294.20%	-2318.08%	-3692.08%	-	-
EBITDA	-112.8	-102.76	-60.65	-91.15	-83.31	-60.83	-39.48	-17.93
EBITDA Margin	-690.16%	-515.22%	-125.79%	-2257.79%	-1908.50%	-5124.26%	-	-
Depreciation & Amortization	21.65	15.69	14.4	14.16	11.13	3.96	1.97	0.82
EBIT	-134.45	-118.45	-75.05	-105.3	-94.43	-64.79	-41.45	-18.75
EBIT Margin	-822.65%	-593.89%	-155.65%	-2608.42%	-2163.41%	-5457.96%	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).